Authors:
Monali Tayade, Shishanka Wangnoo
Download free PDF
Medical Imaging Market Size & Share 2026-2035
Report ID: GMI4786
|
Published Date: August 2026
|
Report Format: PDF/Excel/Dashboard/Platform
Download Free PDF
Explore Our Licensing Options:
Download Free PDF
Medical Imaging Market
Get a free sample of this report
Get a free sample of this report Medical Imaging Market
Is your requirement urgent? Please give us your business email
for a speedy delivery!
Medical Imaging Market Size
The medical imaging market was estimated at approximately USD 46 billion in 2025 and is projected to increase from USD 48.3 billion in 2026 to USD 80.9 billion by 2035, reflecting a 5.9% CAGR.
Medical Imaging Market Key Takeaways
Market Leader: GE HealthCare led with over 31.7% market share in 2025.
Leading Players: Top 5 players in this market include GE HealthCare, Siemens Healthineers, Koninklijke Philips, Canon, Fujifilm Holdings, which collectively held a market share of 89.5% in 2025.
The forecast acceleration rests on a more demanding clinical workload and on a change in how imaging systems are deployed. Noncommunicable diseases caused at least 43 million deaths in 2021, including about 19 million from cardiovascular diseases and about 10 million from cancer [1]World Health Organization, Noncommunicable diseases, who.int. At the same time, the population aged 60 years and older is expected to rise from 1 billion in 2020 to 1.4 billion in 2030 and 2.1 billion in 2050 [2]World Health Organization, Ageing and health, who.int. These conditions raise demand for repeated, modality-specific imaging rather than only episodic diagnostic examinations.
Capital availability also matters because imaging purchases are concentrated in hospital and outpatient capital budgets. U.S. national health expenditures rose 7.2% to USD 5.3 trillion in 2024, equal to 18.0% of GDP . In parallel, vendors are making replacement decisions more clinically and operationally consequential: digital radiography platforms embed automated positioning and wireless detectors, while CT and MR vendors combine faster acquisition with reconstruction and workflow software. The resulting value proposition is increasingly tied to throughput, dose management, staffing pressure, and service continuity, not simply image quality.
GMI Analyst View
The shift from 4.6% historic growth to a 5.9% forecast CAGR indicates that demand is moving beyond a conventional replacement cycle. Aging and chronic-disease prevalence expand examination volumes, while automation, lower-resource MR architectures, and software-supported workflow give providers a reason to refresh installed systems earlier when labor or capacity is constrained. The commercial consequence is a widening distinction between equipment that lowers the cost per completed examination and equipment that adds capability without easing the operating bottleneck.
Growth should therefore not be read as uniform demand for high-end scanners. Mature health systems are likely to weigh utilization, service coverage, and integration against capital cost, whereas regions building diagnostic capacity can favor dependable, scalable configurations. Suppliers that can translate clinical features into measurable workflow gains, and support them locally over the equipment life cycle, are better positioned than those relying on specification-led differentiation alone.
Key Drivers
Incremental innovations and advancements in medical imaging technology
Innovation is changing the economics of an examination. GE HealthCare's Definium Tempo combines automated positioning, an Intelligent Workflow Suite, and wireless FlashPad HD detectors [3]GE HealthCare, Definium Tempo, gehealthcare.com, while Siemens Healthineers positions Multix Impact E around dose-efficient imaging and a rapid digital workflow . Such features can reduce preparation and repeat-image friction in high-volume radiography. In CT and MR, faster acquisition, reconstruction software, compact designs, and reduced cryogen requirements broaden the set of sites that can consider upgrades. The advantage accrues when clinical productivity and serviceability are demonstrable, rather than when systems merely add features.
Rise in healthcare expenditure
Higher health spending enlarges the pool from which imaging equipment, service contracts, and diagnostic capacity are funded. The United States' USD 5.3 trillion health expenditure in 2024 provides a large funding backdrop for technology renewal . The effect is not automatic: imaging suppliers benefit most where budget growth is converted into capital plans, reimbursement-supported scans, and workforce capacity. This makes financing structures, installed-base service, and upgrade pathways important routes to capture expenditure growth.
Increasing disease burden along with rapidly growing geriatric population base
Cancer, cardiovascular disease, and age-related comorbidity require serial detection, staging, surveillance, and intervention support across multiple modalities. WHO reports that noncommunicable diseases accounted for at least 43 million deaths in 2021 , and the number of people aged 60 years and older is set to reach 1.4 billion by 2030 . That combination supports durable demand for imaging capacity, but it also shifts purchasing toward protocols that can handle repeat examinations efficiently and consistently. Providers with constrained specialist capacity have a stronger incentive to standardize acquisition and reading workflows.
Emergence of artificial intelligence (AI) in radiology
AI is becoming relevant where it is embedded in acquisition, reconstruction, measurement, and workflow rather than offered as a detached analytic layer. Samsung Medison introduced the HERA Z20 OB/GYN ultrasound system with Live ViewAssist, Live Q-scan, and A-Focus functions in September 2024 [4]Samsung Global Newsroom, HERA Z20 ultrasound system at ISUOG World Congress 2024, news.samsung.com. Philips' EPIQ Elite incorporates automation including Smart View Select, Auto Measure Abdomen, and Next Gen Auto Scan . These tools can make examination quality less dependent on individual technique and can shorten routine tasks, although clinical validation, interoperability, cybersecurity, and reimbursement still determine the speed of adoption.
Favorable government initiatives
Public investment and screening priorities can unlock demand where private capital alone would not build imaging capacity. Saudi Arabia allocated SAR 189 billion to health and social development in its 2023 budget . Government-backed diagnostic expansion can increase demand for systems, installation, training, and maintenance, particularly where national access objectives create new sites outside major metropolitan hospitals. Procurement cycles remain lumpy, however, and vendors must align local service, compliance, and lifecycle support with tender requirements.
Key Restraints
High cost of imaging devices
High acquisition cost remains the central constraint because a scanner purchase also requires room preparation, shielding or infrastructure where applicable, installation, applications training, maintenance, and downtime planning. The constraint is most severe for advanced CT and MR systems and for smaller providers with uneven utilization. Reduced-helium and smaller-footprint MR designs can lower parts of the ownership burden: Siemens Healthineers describes MAGNETOM Free.Max as using less than one liter of helium with an under-250-square-foot footprint . Even so, lower infrastructure requirements do not remove financing, staffing, and service constraints.
Changes in reimbursement policies
Reimbursement changes affect both scan volumes and the business case for modality upgrades. When payment rules narrow covered indications, reduce technical reimbursement, or increase documentation requirements, providers may defer capital commitments even when clinical demand is present. Conversely, predictable coverage supports diagnostic-center utilization and makes service-contract and financing models more viable. The restraint is therefore less about a single policy direction than about revenue uncertainty across imaging sites and procedures.
GMI Analyst View
The driver and restraint balance favors vendors that can lower the practical cost of capacity, not only the purchase price of a system. AI-supported standardization, faster workflow, and compact or low-helium designs improve the return on an installed asset, while reimbursement uncertainty and high upfront expenditure make isolated feature upgrades harder to justify. The impact estimates above are GMI scenario assessments: their net relationship is aligned with the 5.9% forecast CAGR, but individual effects overlap and should not be treated as independently additive.
Capital allocation is likely to concentrate around platforms that protect utilization across the installed base. That shifts competitive emphasis toward applications support, remote service, software upgrades, financing, and interoperability. A supplier able to prove fewer repeat scans or shorter room time can defend premium positioning; a supplier without that evidence faces greater exposure to tender-led price competition and deferred replacement cycles.
Medical Imaging Market Segment Analysis
By Product
X-ray devices are the largest product segment, valued at USD 14.1 billion in 2025 and projected to reach USD 24 billion by 2035 at a 5.6% CAGR. Digital direct-radiography and computed-radiography systems are displacing analog workflows because image availability, detector flexibility, and workflow integration matter in routine, high-volume care. Analog equipment remains relevant where capital constraints and installed infrastructure dominate, but it offers less scope for the automation and connectivity that support repeatable throughput.
MRI is projected to grow at a 6.7% CAGR and reach USD 13.7 billion by 2035. The category's soft-tissue capability remains a clinical anchor, but adoption is increasingly shaped by infrastructure and operating constraints. GE HealthCare's SIGNA Hero uses reduced-helium technology, with 67% lower helium than prior models, alongside AI-enabled workflow tools [5]GE HealthCare, SIGNA Hero wide-bore MRI scanner, gehealthcare.com. Philips' BlueSeal portfolio is presented as a helium-free 1.5T MR portfolio with a sealed design that eliminates helium refills . These approaches address different ownership constraints and should not be treated as equivalent technical claims.
Ultrasound is expected to expand at a 6.0% CAGR to USD 16.1 billion by 2035. Its portability and real-time use support bedside, ambulatory, and specialty workflows, while 2D systems retain broad routine demand and 3D systems serve applications that benefit from volumetric visualization. Other ultrasound formats can extend access at the point of care. The commercial challenge is to combine portability with consistent image acquisition and documentation, an area where embedded automation can matter.
Computed tomography is forecast to grow at a 6.3% CAGR and reach USD 14 billion by 2035. CT demand is supported by acute-care pathways and the need for rapid, high-resolution examinations. Siemens Healthineers states that SOMATOM X.ceed can scan at up to 261 mm/s and has a rotation time as low as 0.25 seconds [6]Siemens Healthineers, SOMATOM X.ceed, siemens-healthineers.com. Performance of this type has value where time-sensitive pathways and patient motion influence usable image quality, although site volume and protocol mix determine the realized return. Nuclear imaging and mammography remain integral parts of the product mix because they address functional imaging and breast-screening pathways that are not interchangeable with general radiography, CT, or MRI.
By End Use
Hospitals held the largest end-use share at 52.5% in 2025. Their modality mix reflects emergency, inpatient, surgical, oncology, and specialty-care pathways, making integration with enterprise workflow and dependable uptime central purchasing criteria. Hospitals can also consolidate demand across departments, which favors vendors able to support multi-modality fleets.
Diagnostic centers are projected to grow at a 6.3% CAGR and reach USD 25.3 billion by 2035. Their economics are more directly tied to appointment throughput, waiting times, payer mix, and protocol standardization. This creates a strong incentive for systems that shorten room time and enable consistent exams across operators. Other end users, including clinics, research institutions, and point-of-care settings, are projected to grow at a 5.9% CAGR to USD 14 billion by 2035; compact systems and specialized workflows are more important here than the broad multi-modality capability required by hospitals.
GMI Analyst View
The segment mix reveals a two-speed market. X-ray remains the largest pool because it is embedded in routine care and has a broad installed base, but the faster MRI, CT, and ultrasound trajectories reflect demand for higher clinical specificity, time-sensitive diagnosis, and decentralized access. That tension creates different competitive leverage points: radiography vendors must defend workflow and total cost of ownership at scale, while advanced-modality vendors must show that technical performance converts into capacity, protocol reliability, or lower infrastructure burden.
End-use economics sharpen this divergence. Hospitals reward fleet integration and uptime across complex care pathways; diagnostic centers monetize utilization more directly; other end users need systems adapted to narrower spaces and use cases. A single product architecture will not optimize all three. Modular software, applications support, and service models can therefore be as decisive as hardware configuration in converting segment growth into share gains.
Medical Imaging Market Regional Analysis
North America
North America was valued at USD 17.5 billion in 2025, representing about 38% of the global market, and is forecast to reach USD 29.4 billion by 2035 at a 5.42% CAGR. The U.S. market is projected to rise from USD 15.8 billion in 2025 to USD 26.4 billion in 2035 at a 5.38% CAGR, while Canada is projected to grow from USD 1.74 billion in 2025 at a 5.80% CAGR. In the U.S., an estimated 2,001,140 new cancer cases and 611,720 cancer deaths were expected in 2024 [7]American Cancer Society, Cancer Facts & Figures 2024, cancer.org. High disease burden, a large capital base, and reimbursement-linked utilization favor upgrades that can demonstrate workflow, quality, and service value rather than equipment performance in isolation.
Europe
Europe was valued at USD 13.5 billion in 2025 and is projected to reach USD 23.8 billion by 2035 at a 5.95% CAGR. The region recorded 2.74 million new cancer cases in 2022, up 2.3% from 2020 [8]European Commission Joint Research Centre, Cancer cases and deaths rise in the EU, joint-research-centre.ec.europa.eu. Germany, the UK, France, Spain, Italy, and the Netherlands collectively present a mix of mature installed bases, aging populations, and public procurement conditions. Demand for MR, CT, and hybrid imaging modernization must be balanced against budget discipline, tender requirements, and workforce availability, giving lifecycle costs and interoperability substantial weight.
Asia Pacific
Asia Pacific is projected to expand from USD 10.5 billion in 2025 to USD 19.7 billion in 2035 at a 6.59% CAGR, the fastest among the quantified regions. Asia accounted for an estimated 49.2% of global cancer cases in 2022 . In Japan, the population aged 65 years and older was 36.243 million, or 29.3% of the total population, in 2024 , and the country recorded about 371,917 cardiovascular deaths in 2021 . China, Japan, India, Australia, and South Korea combine high-acuity demand with uneven access and procurement conditions. The regional opportunity includes premium replacement in mature systems as well as capacity expansion in markets where access, local service, and affordability determine adoption.
Latin America
Latin America was valued at USD 3.1 billion in 2025 and is forecast to reach USD 5.7 billion by 2035 at a 6.27% CAGR. Brazil, Mexico, and Argentina are the named markets in scope. Brazil is expected to record 704,000 new cancer cases annually during 2023-2025 . The clinical requirement supports diagnostic capacity, but currency exposure, public procurement, and uneven specialist availability can lengthen conversion cycles. Solutions that combine dependable uptime, training, and adaptable financing are likely to be more relevant than narrowly optimized premium specifications.
Middle East & Africa
South Africa, Saudi Arabia, and the UAE form the named Middle East & Africa scope. No regional market value is stated here. Public health investment provides a relevant demand signal: Saudi Arabia's 2023 budget allocated SAR 189 billion to health and social development . The commercial opportunity is heterogeneous, with advanced referral centers and broader access-expansion needs existing simultaneously. Tender readiness, local applications expertise, and maintenance capability are important prerequisites for converting policy ambition into durable imaging capacity.
GMI Analyst View
Regional growth is asymmetric around the 5.9% global forecast. Asia Pacific and Latin America outpace the global rate at 6.59% and 6.27%, respectively, because they combine unmet capacity needs with a rising chronic-disease load; their growth, however, is more exposed to affordability, procurement, and service execution. North America and Europe provide larger, more established revenue pools, but replacement decisions there are increasingly governed by workflow proof, lifecycle economics, and reimbursement or tender discipline.
For entrants, the next marginal opportunity is not simply the highest-growth geography. It lies where a vendor can match product configuration, financing, and local support to the site's operating constraint. Incumbents retain an advantage in installed-base service and enterprise integration in mature markets, while challengers can gain ground in expanding systems when they reduce infrastructure burden, shorten deployment, and sustain applications support after installation.
Medical Imaging Market Share & Competitive Landscape
GE HealthCare, Siemens Healthineers, Koninklijke Philips, Canon, and Fujifilm Holdings collectively account for 89.5% of the market, per GMI analysis. Their position reflects breadth across modalities, installed-base relationships, software development, and service reach rather than a single device category. GE HealthCare reported approximately 51,000 colleagues globally as of December 31, 2023 [9]GE HealthCare, Annual Report 2023, investor.gehealthcare.com, and Philips describes a team of approximately 69,700 people operating across more than 100 countries . Scale can support applications training and maintenance coverage, which are material differentiators when providers assess a system's availability over its life cycle.
The wider competitive field comprises Canon, Carestream Health, Esaote, Fujifilm Holdings, GE HealthCare, Hologic, Konica Minolta, Koninklijke Philips, Mindray Medical, Neusoft Medical Systems, Samsung Medison, Shimadzu, Siemens Healthineers, Synaptive Medical, and United Imaging Healthcare. Competitive intensity differs by modality and site type. Canon Medical's portfolio includes Aquilion Precision, described as an ultra-high-resolution CT system with 150-micron resolution, and the Aquilion ONE/INSIGHT Edition platform . Such modality-specific capability matters, but long-term share also depends on software integration, procurement fit, clinical training, and predictable service delivery.
Recent Industry Developments
Need a specific section of this report?
Purchase regional analysis, country-level analysis, company profiles, or any other segment-level insights separately
based on your research needs.
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Industry journals, trade publications, and specialized media.
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 20+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →